US Patent Issued to Inhibrx Biosciences on March 31 for "5T4 single domain antibodies and therapeutic compositions thereof" (California Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,169, issued on March 31, was assigned to Inhibrx Biosciences Inc. (La Jolla, Calif.).

"5T4 single domain antibodies and therapeutic compositions thereof" was invented by John C. Timmer (La Jolla, Calif.), Michael D. Kaplan (La Jolla, Calif.), Katelyn M. Willis (La Jolla, Calif.), Rajay A. Pandit (La Jolla, Calif.), Angelica N. Sanabria (La Jolla, Calif.), Sydney A. Barnes (La Jolla, Calif.), Margaret E. Haerr (La Jolla, Calif.), Brendan P. Eckelman (La Jolla, Calif.) and Rutger H. Jackson (La Jolla, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are binding polypeptides that specifically bind 5T4. More specifically, provided ...